DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

The Top Three Things to Know about the Top Three Risk Management Issues

by Charles D. Cash, JD, LLM Mr. Cash is Assistant Vice President at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures:

Editorial Message and Issue Highlights–Vol. 16, No. 1–2, January-February 2019

Dear Colleagues: Welcome to the January–February 2019 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a review article by Yeo et al titled, “Virtual Reality Neurorehabilitation

Virtual Reality Neurorehabilitation for Mobility in Spinal Cord Injury: A Structured Review

by Elizabeth Yeo, BS; Brian Chau, MD; Bradley Chi, BS; David E. Ruckle, BS; and Phillip Ta, MD Ms. Yeo, Dr. Chau, Mr. Chi, and Dr. Ta are with the

Exploring the Potential Psychiatric Implications of Astronomical Phenomena

by Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; Michaela Camille Lysogorski, PharmD; and Eileen Trigoboff, RN, RMHCNS-BC, DNS, DABFN Drs. Demler and Trigoboff are with the University of Buffalo,

Brain Imaging in New Onset Psychiatric Presentations

by Evelyne Baroud, MD; Roula Hourani, MD; and Farid Talih, MD Drs. Baroud and Talih are with the Department of Psychiatry, American University of Beirut Medical Center in Beirut, Lebanon.

Synthetic Cannabinoids—”Spice” Can Induce a Psychosis: A Brief Review

by Rajashekar Reddy Yeruva, MD; Hema Madhuri Mekala, MD; Meesha Sidhu MD; and Steven Lippmann, MD Drs. Yeruva and Lippmann are with the University of Louisville School of Medicine in